R.A. Session is the founder of Taysha Gene Therapies. Taysha Gene Therapies has raised $30M in total funding. Latest round: Seed.
R.A. Session II is the President, CEO, and Founder of Taysha Gene Therapies, a biotech startup focused on developing therapies for severe and life-threatening monogenic central nervous system (CNS) diseases. The company launched with $30 million in seed financing and a strategic partnership with the UT Southwestern Gene Therapy Program. Taysha Gene Therapies was founded in 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library